Overview

PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)

Status:
Completed

Trial end date:
2008-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to use functional magnetic resonance imaging (fMRI) in healthy controls to examine the acute effects of certain anxiolytic medications on brain function.

Phase:

Phase 4

Details

Lead Sponsor:

University of California, San Diego

Collaborator:

National Institute of Mental Health (NIMH)

Treatments:

Alprazolam
Anti-Anxiety Agents